Total Intravenous Anesthesia (TIVA): Organized Educational Overview
Definition and Core Concept
TIVA is the maintenance of general anesthesia using exclusively intravenous agents—a combination of hypnotic, analgesic, and muscle relaxant drugs—without any inhaled anesthetic agents 1. This technique provides complete anesthesia through continuous or intermittent IV administration, typically using infusion pumps for precise control 2.
Ideal Characteristics of TIVA Drugs
Hypnotic Agents - Essential Properties:
- Rapid onset and offset allowing smooth induction and quick recovery
- Predictable dose-plasma-effect relationship for tight control of anesthetic depth 3
- Rapid elimination from circulation enabling close titration 3
- Minimal accumulation in peripheral compartments
- Cardiovascular stability with minimal depression
- No respiratory irritation (unlike some inhaled agents)
- Low incidence of postoperative nausea and vomiting (PONV) 4
Analgesic Agents - Essential Properties:
- Potent analgesia at sub-respiratory depressant doses
- Rapid onset and offset for intraoperative titration
- Predictable pharmacokinetics suitable for continuous infusion
- Minimal hemodynamic effects
- Context-sensitive half-time allowing timely emergence
Drug Categories and Specific Agents
1. HYPNOTICS (Induction and Maintenance)
Propofol (Gold Standard)
- Primary choice for TIVA with many characteristics of the ideal IV anesthetic 5
- Rapid, smooth induction with rapid clearance 5
- Avoids claustrophobia associated with mask induction 5
- Reduces PONV incidence 4
- Dosing: Loading dose followed by continuous infusion to maintain plasma concentrations in hypnotic range 3
- Caveat: Environmental ecotoxicity for water and soils 6—but this should not override clinical benefit
- Typical plasma concentrations: 3-4 μg/mL at end of surgery 3
Methohexital (Alternative)
- Similar pharmacokinetic profile to propofol 3
- Acceptable alternative when propofol unavailable
- May cause more restlessness postoperatively 3
- Longer recovery time (median 50 min vs 25 min for propofol) 3
Ketamine (Adjunct/Alternative)
- Used in combination regimens, particularly in resource-limited settings 1
- Provides analgesia and amnesia
- Maintains cardiovascular stability
- Useful in hemodynamically unstable patients
Emerging Agents
- Ciprofol and remimazolam are newer drugs being investigated to potentially upgrade TIVA practice 7
2. ANALGESICS (Maintenance)
Opioids - The Backbone
Alfentanil:
- Commonly used in TIVA combinations 3
- Typical dosing: 0.1 mg/kg initial, 0.125 mg/kg/h maintenance 3
- Stopped 30 minutes before end of surgery 3
Fentanyl:
- Widely used, well-established profile 1
- Longer duration than alfentanil
- Suitable for longer procedures
Sufentanil:
- More potent than fentanyl
- Useful for major surgery requiring intense analgesia 1
Remifentanil:
- Ultra-short acting with context-insensitive half-time
- Ideal for precise titration
- Requires transition to longer-acting opioid before emergence
3. MUSCLE RELAXANTS
- Not specific to TIVA—same agents used as in balanced anesthesia
- Choice based on duration of surgery, intubating conditions, and reversal needs
- Examples: rocuronium, vecuronium, atracurium, cisatracurium
Clinical Implementation Algorithm
Step 1: Patient Selection
- TIVA is appropriate for virtually all patients but particularly beneficial in:
Step 2: Equipment Requirements
- Infusion pumps (preferably target-controlled infusion [TCI] systems) 6
- Depth of anesthesia monitoring to reduce drug consumption 6, 2
- Backup IV access
- Standard monitoring equipment
Step 3: Drug Preparation
- Prepare medications just before use, not systematically beforehand 6
- Use pre-filled syringes for occasionally used medicines when available 6
- Label all syringes clearly
Step 4: Induction Protocol
- Propofol: Bolus dose (1.5-2.5 mg/kg) OR start infusion with loading scheme
- Opioid: Bolus (e.g., alfentanil 10-20 μg/kg, fentanyl 1-3 μg/kg)
- Muscle relaxant: As needed for intubation
Step 5: Maintenance Protocol
- Two-step infusion approach 3:
- Loading phase to fill peripheral compartments
- Maintenance phase to sustain therapeutic plasma levels
- Propofol: Typically 4-12 mg/kg/h (adjust based on depth monitoring)
- Opioid: Continuous infusion (e.g., alfentanil 0.5-2 μg/kg/min)
- Monitor depth of anesthesia continuously to optimize drug consumption 6, 2
Step 6: Inadequate Depth Management
If signs of light anesthesia (HR or SBP >25% above baseline) 3:
- First: Bolus opioid (e.g., alfentanil 0.5-1 mg)
- If ineffective: Bolus hypnotic (e.g., propofol 50 mg)
- Increase maintenance infusion rates
Step 7: Emergence Protocol
- Stop opioid infusion 30 minutes before end of surgery 3
- Stop hypnotic at skin closure
- Recovery time varies by agent (propofol ~25 min, methohexital ~50 min) 3
Advantages of TIVA
- Precise control of anesthetic depth with continuous infusion 5
- Reduced PONV compared to volatile agents 4
- Better airway and hemodynamic control 4
- Avoids volatile agent contraindications (malignant hyperthermia susceptibility)
- No pollution of operating room environment with anesthetic gases
- Applicable in field conditions without sophisticated vaporizers 1
- Reduced greenhouse gas emissions compared to volatile agents (though propofol has water/soil ecotoxicity) 6
Disadvantages and Pitfalls
Common Pitfalls:
Delayed emergence if infusions not stopped appropriately
- Solution: Stop opioid 30 min before end, stop hypnotic at closure 3
Awareness risk without depth monitoring
Accumulation with prolonged infusions
- Solution: Use TCI systems with pharmacokinetic models 6
IV line failure = complete loss of anesthesia
- Solution: Secure IV access, consider backup line for long cases
Shivering (particularly with methohexital, 56% incidence) 3
- Solution: Prefer propofol (0% shivering incidence) 3
Hypotension on induction (30-37% drop in systolic BP) 3
- Solution: Slower induction, adequate preload, vasopressors ready
Environmental Considerations
With equal clinical benefit, anesthesia professionals may choose either TIVA or volatile anesthesia 6. The guideline emphasizes:
- Volatile agents have greenhouse gas emissions
- Propofol has ecotoxicity for water and soils
- Clinical benefit to the patient takes priority over environmental concerns 6
- When using TIVA, monitor depth to reduce drug consumption 6
Key Guideline Recommendations
From the Association of Anaesthetists and Society for Intravenous Anaesthesia 2:
- All anaesthetists should be competent in delivering TIVA safely
- TIVA encompasses pure IV techniques and combinations with inhalational agents
- Safety protocols must be followed rigorously
From expert consensus 4:
- Cost, lack of familiarity, and delayed emergence are NOT considered obstacles to TIVA use
- Primary motivations: patient experience (especially pediatrics) and procedure outcomes
- PONV reduction and physiological control are priorities
Exam Key Points Summary
Definition: IV hypnotic + IV analgesic + muscle relaxant, NO inhaled agents 1
Ideal drug characteristics: Rapid onset/offset, predictable dose-effect, rapid elimination, minimal accumulation 3
Gold standard combination: Propofol + opioid (alfentanil/fentanyl/remifentanil) 5, 3
Mandatory monitoring: Depth of anesthesia monitoring 6, 2
Timing: Stop opioid 30 min before end, stop hypnotic at closure 3
Main advantages: PONV reduction, precise control, no volatile contraindications 4
Main pitfall: Awareness without monitoring; IV failure = no anesthesia 2